EMAIL ALERTS
You may automatically receive Cytokinetics, Inc. financial information by email. To choose your options for email notification, please enter your email address below and click Submit.
- Our Focus
We are developing potential medicines to improve the healthspan of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.
- Pipeline
We’re advancing muscle biology-driven treatments for diseases characterized by compromised muscle function, muscle weakness, and fatigue.
- Clinical Trials
We have conducted more than 50 clinical trials as we strive to bring important new medicines to patients with diseases like ALS, heart failure, HCM and SMA.
- Company
Our diverse, inclusive and respectful culture is foundational to our success and essential to building a strong team.
- Culture
Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing muscle activators and inhibitors.
- Investors & Media
Cytokinetics’ unparalleled expertise has kept it at the forefront of drug discovery and development for diseases impacting muscle performance.